nach oben

Endocrine

Erschienen in:

01.02.2015 | Mini Review

Pituitary apoplexy

verfasst von: Wenya Linda Bi, Ian F. Dunn, Edward R. Laws Jr.

Erschienen in: Endocrine | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Pituitary apoplexy is a clinical syndrome of sudden headache and visual decline associated with acute hemorrhagic or ischemic change of an intrasellar mass, and comprises only a subset of hemorrhagic pituitary lesions. The most common presenting symptoms include headache, nausea, diminished visual acuity or visual field, ophthalmoplegia/paresis, and impaired mental status. Multiple risk factors have been reported, although the majority of cases have no identifiable precipitants. MRI is the most sensitive diagnostic modality, with specific imaging findings dependent on the timing post-hemorrhage. Early clinical suspicion is imperative to allow for corticosteroid replacement and hemodynamic stabilization when indicated. Transsphenoidal surgical decompression improves outcome in a majority of cases, although conservative management may be appropriate in select scenarios.

H.S. Randeva, J. Schoebel, J. Byrne, M. Esiri, C.B. Adams, J.A. Wass, Classical pituitary apoplexy: clinical features, management and outcome. Clin. Endocrinol. 51(2), 181–188 (1999)CrossRef

P.L. Semple, M.K. Webb, J.C. de Villiers, E.R. Laws Jr., Pituitary apoplexy. Neurosurgery 56(1), 65–72; discussion 72–63 (2005)

P. Bailey, Pathological report of a case of akromegaly, with special reference to the lesions in the hypophysis cerebri and in the thyroid gland; and a case of haemorrhage into the pituitary. Phila. Med. J. 1, 789–792 (1898)

M. Brougham, A.P. Heusner, R.D. Adams, Acute degenerative changes in adenomas of the pituitary body—with special reference to pituitary apoplexy. J. Neurosurg. 7(5), 421–439 (1950). doi:10.3171/jns.1950.7.5.0421 CrossRefPubMed

S.S. Chhiber, A.R. Bhat, S.H. Khan, M.A. Wani, A.U. Ramzan, A.R. Kirmani, N.K. Malik, A.A. Wani, T. Rather, Apoplexy in sellar metastasis: a case report and review of literature. Turk. Neurosurg. 21(2), 230–234 (2011). doi:10.5137/1019-5149.JTN.2716-09.1 PubMed

R.L. Rovit, J.M. Fein, Pituitary apoplexy: a review and reappraisal. J. Neurosurg. 37(3), 280–288 (1972). doi:10.3171/jns.1972.37.3.0280 CrossRefPubMed

G. Mohr, J. Hardy, Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg. Neurol. 18(3), 181–189 (1982)CrossRefPubMed

S. Wakai, T. Fukushima, A. Teramoto, K. Sano, Pituitary apoplexy: its incidence and clinical significance. J. Neurosurg. 55(2), 187–193 (1981). doi:10.3171/jns.1981.55.2.0187 CrossRefPubMed

D.C. Bills, F.B. Meyer, E.R. Laws Jr., D.H. Davis, M.J. Ebersold, B.W. Scheithauer, D.M. Ilstrup, C.F. Abboud, A retrospective analysis of pituitary apoplexy. Neurosurgery 33(4), 602–608; discussion 608–609 (1993)

10.

W. Bonicki, A. Kasperlik-Zaluska, W. Koszewski, W. Zgliczynski, J. Wislawski, Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas. Acta Neurochir. 120(3–4), 118–122 (1993)CrossRefPubMed

11.

M.J. Ebersold, E.R. Laws Jr., B.W. Scheithauer, R.V. Randall, Pituitary apoplexy treated by transsphenoidal surgery. A clinicopathological and immunocytochemical study. J. Neurosurg. 58(3), 315–320 (1983). doi:10.3171/jns.1983.58.3.0315 CrossRefPubMed

12.

J.W. Findling, J.B. Tyrrell, D.C. Aron, P.A. Fitzgerald, C.B. Wilson, P.H. Forsham, Silent pituitary apoplexy: subclinical infarction of an adrenocorticotropin-producing pituitary adenoma. J. Clin. Endocrinol. Metab. 52(1), 95–97 (1981). doi:10.1210/jcem-52-1-95 CrossRefPubMed

13.

P. Maccagnan, C.L. Macedo, M.J. Kayath, R.G. Nogueira, J. Abucham, Conservative management of pituitary apoplexy: a prospective study. J. Clin. Endocrinol. Metab. 80(7), 2190–2197 (1995). doi:10.1210/jcem.80.7.7608278 PubMed

14.

S.G. Ostrov, R.M. Quencer, J.C. Hoffman, P.C. Davis, A.N. Hasso, N.J. David, Hemorrhage within pituitary adenomas: how often associated with pituitary apoplexy syndrome? AJR Am. J. Roentgenol. 153(1), 153–160 (1989). doi:10.2214/ajr.153.1.153 CrossRefPubMed

15.

W. Muller, H.W. Pia, Clinical aspects and etiology of massive hemorrhage in pituitary adenoma. Deutsche Zeitschrift fur Nervenheilkunde 170(4), 326–336 (1953)PubMed

16.

A. Jahangiri, A.J. Clark, S.J. Han, S. Kunwar, L.S. Blevins Jr., M.K. Aghi, Socioeconomic factors associated with pituitary apoplexy. J. Neurosurg. 119(6), 1432–1436 (2013). doi:10.3171/2013.6.JNS122323 CrossRefPubMed

17.

V. Biousse, N.J. Newman, N.M. Oyesiku, Precipitating factors in pituitary apoplexy. J. Neurol. Neurosurg. Psychiatry 71(4), 542–545 (2001)CrossRefPubMedCentralPubMed

18.

M. Peter, N. De Tribolet, Visual outcome after transsphenoidal surgery for pituitary adenomas. Br. J. Neurosurg. 9(2), 151–157 (1995)CrossRefPubMed

19.

R.M. McFadzean, D. Doyle, R. Rampling, E. Teasdale, G. Teasdale, Pituitary apoplexy and its effect on vision. Neurosurgery 29(5), 669–675 (1991)CrossRefPubMed

20.

H.J. Woo, J.H. Hwang, S.K. Hwang, Y.M. Park, Clinical outcome of cranial neuropathy in patients with pituitary apoplexy. J. Korean Neurosurg. Soc. 48(3), 213–218 (2010). doi:10.3340/jkns.2010.48.3.213 CrossRefPubMedCentralPubMed

21.

S.H. Kim, K.C. Lee, S.H. Kim, Cranial nerve palsies accompanying pituitary tumour. J. Clin. Neurosci. 14(12), 1158–1162 (2007). doi:10.1016/j.jocn.2006.07.016 CrossRefPubMed

22.

C.M. Robert Jr., J.A. Feigenbaum, E.W. Stern, Ocular palsy occurring with pituitary tumors. J. Neurosurg. 38(1), 17–19 (1973). doi:10.3171/jns.1973.38.1.0017 CrossRefPubMed

23.

C. Symonds, Ocular palsy as the presenting symptom of pituitary adenoma. Bull Johns Hopkins Hosp. 111, 72–82 (1962)

24.

H. Kobayashi, M. Kawabori, S. Terasaka, J. Murata, K. Houkin, A possible mechanism of isolated oculomotor nerve palsy by apoplexy of pituitary adenoma without cavernous sinus invasion: a report of two cases. Acta Neurochir. 153(12), 2453–2456; discussion 2456 (2011). doi:10.1007/s00701-011-1165-4

25.

S.H. Petermann, N.J. Newman, Pituitary macroadenoma manifesting as an isolated fourth nerve palsy. Am. J. Ophthalmol. 127(2), 235–236 (1999)CrossRefPubMed

26.

R.F. Saul, J.K. Hilliker, Third nerve palsy: the presenting sign of a pituitary adenoma in five patients and the only neurological sign in four patients. J. Clin. Neuroophthalmol. 5(3), 185–193 (1985)PubMed

27.

G. Jefferson, Extrasellar extensions of pituitary adenomas: (Section of Neurology). Proc. R. Soc. Med. 33(7), 433–458 (1940)PubMedCentralPubMed

28.

J.D.R. Monro, A case of sudden death: tumour of the pituitary body. Lancet 2, 1539 (1913)CrossRef

29.

J. Ayuk, E.J. McGregor, R.D. Mitchell, N.J. Gittoes, Acute management of pituitary apoplexy—surgery or conservative management? Clin. Endocrinol. 61(6), 747–752 (2004). doi:10.1111/j.1365-2265.2004.02162.x CrossRef

30.

A. Uihlein, W.M. Balfour, P.F. Donovan, Acute hemorrhage into pituitary adenomas. J. Neurosurg. 14(2), 140–151 (1957). doi:10.3171/jns.1957.14.2.0140 CrossRefPubMed

31.

E.R. Cardoso, E.W. Peterson, Pituitary apoplexy: a review. Neurosurgery 14(3), 363–373 (1984)CrossRefPubMed

32.

N. Cinar, Y. Tekinel, S. Dagdelen, H. Oruckaptan, F. Soylemezoglu, T. Erbas, Cavernous sinus invasion might be a risk factor for apoplexy. Pituitary 16(4), 483–489 (2013). doi:10.1007/s11102-012-0444-2 CrossRefPubMed

33.

K.N. Sarwar, M.S. Huda, V. Van de Velde, L. Hopkins, S. Luck, R. Preston, B.M. McGowan, P.V. Carroll, J.K. Powrie, The prevalence and natural history of pituitary hemorrhage in prolactinoma. J. Clin. Endocrinol. Metab. 98(6), 2362–2367 (2013). doi:10.1210/jc.2013-1249 CrossRefPubMed

34.

L.A. Weisberg, Pituitary apoplexy. Association of degenerative change in pituitary ademona with radiotherapy and detection by cerebral computed tomography. Am. J. Med. 63(1), 109–115 (1977)CrossRefPubMed

35.

A.J. Chapman, G. Williams, A.D. Hockley, D.R. London, Pituitary apoplexy after combined test of anterior pituitary function. Br. Med. J. 291(6487), 26 (1985)CrossRef

36.

T. Yamaji, M. Ishibashi, K. Kosaka, T. Fukushima, T. Hori, S. Manaka, K. Sano, Pituitary apoplexy in acromegaly during bromocriptine therapy. Acta Endocrinol. 98(2), 171–177 (1981)PubMed

37.

V. Peck, A. Lieberman, R. Pinto, A. Culliford, Pituitary apoplexy following open-heart surgery. N. Y. State J. Med. 80(4), 641–643 (1980)PubMed

38.

P.L. Semple, J.A. Jane Jr., E.R. Laws Jr., Clinical relevance of precipitating factors in pituitary apoplexy. Neurosurgery 61(5), 956–961; discussion 961–952 (2007). doi:10.1227/01.neu.0000303191.57178.2a

39.

R.L. Reid, M.E. Quigley, S.S. Yen, Pituitary apoplexy. A review. Arch. Neurol. 42(7), 712–719 (1985)CrossRefPubMed

40.

S.H. Wong, K. Das, M. Javadpour, Pituitary apoplexy initially mistaken for bacterial meningitis. BMJ Case Rep. (2013). doi:10.1136/bcr-2013-009223

41.

F.A. Neelon, M.S. Mahaley Jr., Chiasmal syndrome due to intrasellar abscess. Arch. Intern. Med. 136(9), 1041–1043 (1976)CrossRefPubMed

42.

J. Xenellis, J. Stivaktakis, N. Karpeta, D. Rologis, E. Ferekidis, Pituitary apoplexy: a pathologic entity from an otolaryngologist’s view. ORL J. Otorhinolaryngol. Relat. Spec. 65(2), 121–124 (2003)CrossRefPubMed

43.

L.M. Weinberger, F.H. Adler, F.C. Grant, Primary pituitary adenoma and the syndrome of the cavernous sinus: a clinical and anatomic study. Arch. Ophthalmol. 24, 1197–1236 (1940)CrossRef

44.

R.P. Glick, J.A. Tiesi, Subacute pituitary apoplexy: clinical and magnetic resonance imaging characteristics. Neurosurgery 27(2), 214–218; discussion 218–219 (1990)

45.

M. Piotin, D. Tampieri, D.A. Rufenacht, G. Mohr, M. Garant, R. Del Carpio, F. Robert, J. Delavelle, D. Melanson, The various MRI patterns of pituitary apoplexy. Eur. Radiol. 9(5), 918–923 (1999)CrossRefPubMed

46.

P.C. Davis, J.C. Hoffman Jr., T. Spencer, G.T. Tindall, I.F. Braun, MR imaging of pituitary adenoma: CT, clinical, and surgical correlation. AJR Am. J. Roentgenol. 148(4), 797–802 (1987). doi:10.2214/ajr.148.4.797 CrossRefPubMed

47.

B. Agrawal, K. Dziurzynski, M.S. Salamat, M. Baskaya, The temporal association of sphenoid sinus mucosal thickening on MR imaging with pituitary apoplexy. Turk. Neurosurg. 22(6), 785–790 (2012). doi:10.5137/1019-5149.JTN.4273-11.1 PubMed

48.

K. Arita, K. Kurisu, A. Tominaga, K. Sugiyama, F. Ikawa, H. Yoshioka, M. Sumida, Y. Kanou, K. Yajin, R. Ogawa, Thickening of sphenoid sinus mucosa during the acute stage of pituitary apoplexy. J. Neurosurg. 95(5), 897–901 (2001). doi:10.3171/jns.2001.95.5.0897 CrossRefPubMed

49.

J.K. Liu, W.T. Couldwell, Pituitary apoplexy in the magnetic resonance imaging era: clinical significance of sphenoid sinus mucosal thickening. J. Neurosurg. 104(6), 892–898 (2006). doi:10.3171/jns.2006.104.6.892 CrossRefPubMed

50.

M.T. Schnitker, H.B. Lehnert, Apoplexy in a pituitary chromophobe adenoma producing the syndrome of middle cerebral artery thrombosis; case report. J. Neurosurg. 9(2), 210–213 (1952). doi:10.3171/jns.1952.9.2.0210 CrossRefPubMed

51.

S.K. Ahmed, P.L. Semple, Cerebral ischaemia in pituitary apoplexy. Acta Neurochir. 150(11), 1193–1196; discussion 1196 (2008). doi:10.1007/s00701-008-0130-3

52.

H. Seyer, F. Erbguth, D. Kompf, G. Koniszewski, R. Fahlbusch, Acute hemorrhage and ischemic necroses in hypophyseal tumors: hypophyseal apoplexy. Fortschr. Neurol. Psychiatr. 57(11), 474–488 (1989). doi:10.1055/s-2007-1001144 CrossRefPubMed

53.

S. Rajasekaran, M. Vanderpump, S. Baldeweg, W. Drake, N. Reddy, M. Lanyon, A. Markey, G. Plant, M. Powell, S. Sinha, J. Wass, UK guidelines for the management of pituitary apoplexy. Clin. Endocrinol. 74(1), 9–20 (2011). doi:10.1111/j.1365-2265.2010.03913.x CrossRef

54.

E.R. Laws Jr., J.C. Trautmann, R.W. Hollenhorst Jr., Transsphenoidal decompression of the optic nerve and chiasm. Visual results in 62 patients. J. Neurosurg. 46(6), 717–722 (1977). doi:10.3171/jns.1977.46.6.0717 CrossRefPubMed

55.

J.B. Kerrison, M.J. Lynn, C.A. Baer, S.A. Newman, V. Biousse, N.J. Newman, Stages of improvement in visual fields after pituitary tumor resection. Am. J. Ophthalmol. 130(6), 813–820 (2000)CrossRefPubMed

56.

J.W. Seuk, C.H. Kim, M.S. Yang, J.H. Cheong, J.M. Kim, Visual outcome after transsphenoidal surgery in patients with pituitary apoplexy. J. Korean Neurosurg. Soc. 49(6), 339–344 (2011). doi:10.3340/jkns.2011.49.6.339 CrossRefPubMedCentralPubMed

57.

A.R. Cohen, P.R. Cooper, M.J. Kupersmith, E.S. Flamm, J. Ransohoff, Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurgery 17(3), 446–452 (1985)CrossRefPubMed

58.

P.L. Semple, J.A. Jane, M.B. Lopes, E.R. Laws, Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results. J. Neurosurg. 108(5), 909–915 (2008). doi:10.3171/JNS/2008/108/5/0909 CrossRefPubMed

59.

A. Pal, C. Capatina, A.P. Tenreiro, P.D. Guardiola, J.V. Byrne, S. Cudlip, N. Karavitaki, J.A. Wass, Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences. Clin. Endocrinol. 75(4), 501–504 (2011). doi:10.1111/j.1365-2265.2011.04068.x CrossRef

Titel: Pituitary apoplexy
verfasst von: Wenya Linda Bi
Ian F. Dunn
Edward R. Laws Jr.
Publikationsdatum: 01.02.2015
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 1/2015
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-014-0359-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2015

Should we still be concerned about the potential side effects of glucagon-like peptide-1 receptor agonists on thyroid C cells?

Von Hippel-Lindau disease type 2 in a Chinese family with a VHL p.W88X truncation

Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy

Treatment of hyperprolactinemia in post-menopausal women: pros

Chemical contamination and the thyroid